Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.97
Delayed Data
As of 4:00pm ET
 -0.12 / -1.69%
Today’s Change
4.60
Today|||52-Week Range
8.63
+17.14%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close7.09
Today’s open7.13
Day’s range6.88 - 7.17
Volume686,384
Average volume (3 months)1,383,926
Market cap$588.6M
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)-586.67%
Earnings growth (this year)+9.59%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-83.15%
P/E ratioNM
Price/Sales35.75
Price/Book8.83

Competitors

 Today’s
change
Today’s
% change
ABEOAbeona Therapeutics ...-1.55-7.75%
ASMBAssembly Biosciences...-0.22-0.50%
KPTIKaryopharm Therapeut...-0.43-3.06%
CMTAClementia Pharmaceut...-2.12-10.89%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 11, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$11.7M
Annual profit (last year)-$51.0M
Net profit margin-436.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
CFO, Principal Accounting Officer &
Senior VP
Patrick Fabbio
Corporate headquarters
New York, New York

Forecasts